Clinical outcomes of COVID‐19 treated with remdesivir across the continuum of care

INTRODUCTION: During the early phase of the coronavirus disease 2019 (COVID‐19), remdesivir was only approved for hospitalized patients. Our institution developed hospital‐based, outpatient infusion centers for selected hospitalized patients with COVID‐19 who had clinical improvement to allow for ea...

Descripción completa

Detalles Bibliográficos
Autores principales: Rivera, Christina G., Chesdachai, Supavit, Draper, Evan W., Arndt, Richard F., Mara, Kristin C., Gonzalez Suarez, Maria, Razonable, Raymund R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10205088/
https://www.ncbi.nlm.nih.gov/pubmed/37228805
http://dx.doi.org/10.1111/irv.13136

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10205088/
https://www.ncbi.nlm.nih.gov/pubmed/37228805
http://dx.doi.org/10.1111/irv.13136

Ejemplares similares